- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Psoriasis Plantaris in New Zealand
Total 490 results
-
Taro Pharmaceuticals USACompleted
-
Janssen Research & Development, LLCCompleted
-
Boehringer IngelheimTerminatedPsoriasisUnited States, Canada, Germany
-
Rockefeller UniversityTerminatedObesity | PsoriasisUnited States
-
Janssen Biotech, Inc.Completed
-
Bristol-Myers SquibbCompletedPsoriasisUnited States, Spain, Hungary, Australia, Germany, Canada, Czechia, Poland, Puerto Rico, Finland, France, Israel, Italy, New Zealand, Sweden, United Kingdom
-
Bond Avillion 2 Development LPAvillion LLPCompletedPsoriasisUnited States, Germany, Bulgaria, Canada, Czechia, Hungary, Poland
-
Sirtris, a GSK CompanyGlaxoSmithKlineCompleted
-
Boehringer IngelheimCompletedPsoriasisUnited States, Canada, Germany
-
Hoffmann-La RocheCompletedHIV Infections | PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisGermany, United States, France, Estonia, Canada
-
Incyte CorporationCompleted
-
Bausch Health Americas, Inc.TerminatedPsoriasisUnited States, Australia, France, Canada, Denmark
-
Centocor Research & Development, Inc.CompletedPsoriasisUnited States, Belgium, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisGermany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
-
NYU Langone HealthJanssen Scientific Affairs, LLCRecruiting
-
AmgenTerminatedPsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisGermany, United States, Japan, France, Israel, Norway, Iceland
-
Centocor, Inc.Completed
-
UNION therapeuticsCompletedSkin Diseases | PsoriasisUnited Kingdom, Poland, United States, Germany
-
Boehringer IngelheimCompletedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in PsoriasisPsoriasisUnited States, Germany
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Janssen Inc.CompletedPsoriasisUnited States, Poland, Canada, Belgium, Germany
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
MedImmune LLCCompletedPsoriasisUnited States, Canada
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedPsoriasisUnited States, Canada
-
Dr. Reddy's Laboratories LimitedCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Colombia, Estonia, Japan, Taiwan, Israel, Canada, Lithuania, Argentina, Latvia, Iceland, Mexico
-
Eli Lilly and CompanyTerminated
-
Galderma R&DCompleted
-
Lycera Corp.Completed
-
Bausch Health Americas, Inc.Completed
-
Novo Nordisk A/STerminatedInflammation | PsoriasisUnited States
-
Promius Pharma, LLCCompleted
-
Bristol-Myers SquibbCompletedPsoriasisChina, Korea, Republic of, Spain, United States, United Kingdom, Canada, Russian Federation, Japan, Germany, Poland, Taiwan
-
PfizerCompletedPsoriasisUnited States, Germany, Canada, Denmark, Hungary, Australia, Latvia, Poland, Bulgaria, Japan
-
Eli Lilly and CompanyIncyte CorporationCompletedSkin Diseases | Psoriasis | Skin Diseases, PapulosquamousCanada, Japan, United States, Puerto Rico
-
Eli Lilly and CompanyCompletedPsoriasisUnited States, Germany, Spain, France, Austria, Canada, Poland, Australia, United Kingdom, Romania, Netherlands, Czechia
-
AbbVieActive, not recruitingChronic Plaque PsoriasisArgentina, Australia, Austria, Canada, Colombia, Czechia, France, Germany, Hungary, Ireland, Italy, Japan, Mexico, Netherlands, Poland, Romania, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Eli Lilly and CompanyCompletedPsoriasisUnited States, Hungary, Germany, Canada, Mexico, Bulgaria, Russian Federation, Poland, Argentina, Chile
-
Stiefel, a GSK CompanyGlaxoSmithKlineCompleted
-
Bristol-Myers SquibbActive, not recruitingPsoriasisChina, Taiwan, Spain, United States, Hungary, Canada, Germany, Japan, Australia, Poland, Czechia, United Kingdom, Korea, Republic of, Israel, New Zealand, Sweden, France, Finland, Russian Federation, Puerto Rico
-
PfizerCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
AmgenCompletedPsoriasisUnited States, Poland, Canada, Germany, Estonia, Georgia, Hungary, Latvia
-
Maruho North America Inc.CompletedPsoriasisUnited States
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedPsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Centocor Research & Development, Inc.CompletedPsoriasisUnited States, United Kingdom, Germany, Canada, Austria, France, Switzerland